PREFUNDED COMMON STOCK PURCHASE WARRANT AETHLON MEDICAL, INC.Aethlon Medical Inc • November 15th, 2019 • Laboratory analytical instruments • New York
Company FiledNovember 15th, 2019 Industry JurisdictionTHIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Issue Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aethlon Medical, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
UNDERWRITING AGREEMENTUnderwriting Agreement • November 15th, 2019 • Aethlon Medical Inc • Laboratory analytical instruments • New York
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionThe undersigned, Aethlon Medical, Inc., a company incorporated under the laws of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ASSIGNMENT AGREEMENTAssignment Agreement • November 15th, 2019 • Aethlon Medical Inc • Laboratory analytical instruments • Ontario
Contract Type FiledNovember 15th, 2019 Company Industry JurisdictionThis Agreement is made this 7th day of November, 2006 between London Health Science Center Research Inc., 375 South Street, London Ontario (hereinafter called LHSCRI) and Aethlon Medical Inc. (hereinafter called Aethlon).